Keywords: serono, initiates, ph, iii, rebif, trial, swiss

Serono initiates Ph III Rebif trial

Article | 18 December 2006

Print This

Swiss biotechnology firm Serono has initiated a Phase III trial of a new formulation of its multiple sclerosis drug Rebif ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in